We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Avia Health | LSE:AVIA | London | Ordinary Share | GB00B4YSYV64 | ORD 0.5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.125 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 2.125 | GBX |
Avia Health (AVIA) Share Charts1 Year Avia Health Chart |
|
1 Month Avia Health Chart |
Intraday Avia Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2013 | 07:24 | AVIA Health - interesting listing | 934 |
| 23/10/2013 | 17:00 | AVIA with Charts & News | 2 |
| 21/6/2013 | 13:29 | AVIA Health Informatics - 7p to buy - NO STOCK AVAILABLE | 54 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 05/11/2013 08:39 by encarter ds, yes I can. I once made money out of RAM, also looking at the 5 year TXO chart there's a spike in September 2009 from 1p to 4p, I'm sure plenty made money out of that and the several other jumps in share price I'm confident that we will get a couple of chances here also.The gold price is falling now so I would think again about the direction of your company. Call if Fort Knox Graphene and I might be interested. |
Posted at 29/10/2013 07:16 by knigel encarter, thanks for the link - I definitely need to do more research on grapheme. I remember a while back investing in AVO at 1p because it was involved in proton technology - the share price was static for a year and shareholders not happy - however this year has seen progress and a re-rating as the technology translate into a commercial use. Maybe (just maybe) something similar will happen here over the next 1-2 years? |
Posted at 27/10/2013 22:08 by knigel Please leave TXO issues and grudges to the related thread.It was stated clearly that a minimum £50k was required and up to a maximum £500k in the placing could be raised. In the end it was the mid range £330k pre expenses and repayment of o/s debts. I don't see the point of raising more funds yet (we are not even talking a week yet!) until the first target for investment has been identified. Agree about the premium to NAV comment - it will be difficult for the share price to stay above 2p without news soon |
Posted at 27/10/2013 21:26 by sharptack drunken sailor says above "in short placing by Feb or back into suspension" well I can tell him his forecast is over generous because I know for a fact the man is already at it, sounding out interest in an immediate secondary round of funding.Same old dilution on the cards here. New funding already 69.5% of the enlarged capital, now set to top 80% within days (see below). Fair enough, a new beginning needs funding but if only something good and profitable would ever come of it. If there's a place he's ever made money for smaller investors, I'd really love to see it. Graphene Investor, remarkably chooses this thread for his first ever post and yet already appears to be quite an oracle on TB and ds. Funny that. He says above "The aim was to raise £250k but up to £500k not £500k as reported in the press)" Was it really? Since he seems so well informed why not tell the whole truth? Among several other conditions needing to be satisfied, what I saw myself said minimum funds of at least £300k were required to be raised "in order for the Company to have sufficient working capital to allow Readmission". Of this, about £55k had already been raised at the time of the placing document. Surely only an insider would therefore talk of aiming to raise £250k [i.e. £250k more]?? Oh dear, GI, soooo transparent! So, far from the misleading impression our insider wants to give out, it's plain they only just got over the line or it would have been curtains! This is a matter of record, not my opinion. No wonder he's straight back out there looking for more - up to £250k more within a couple of weeks I gather, at the same price. The press were not so wrong after all then Graphene mate! It's plain that if £300k was the bare minimum to pay off commitments and also provide minimal working capital to allow the thinnest of going concerns, then all that'll shortly remain from this is the minimal working capital part. At about £550k market cap and surely nothing left from this first tranche for investment purposes, it looks challenging to say the least. Quite what value they can bring in from the anticipated new tranche remains to be seen but if they do manage to get the second tranche away for a full £250k it'll also only come along with another 12.5 shares and a new market cap of about £850k at current sp, against cash assets of only about £300k I'd estimate. Quite a challenge for them then. On the face of it, any investments they could actually afford for cash would have to near double to fill the valuation gap, let alone create new shareholder value. However, that would leave no working cap. I therefore see any acquisitions being mainly for shares. If so, the dilution cycle continues on and on and on. Fact is that most investment companies trade at a discount. That this one is already at a substantial premium to net assets rings alarm bells for near term share price progress. TB's history only accentuates that. |
Posted at 26/10/2013 08:42 by knigel o/t TXO might be a decent punt at the moment because there's a court case on going were there might be a significant settlement payout... Not sure about the name Cientifica but there is no way they can keep the name Avia - it's too painful for the older shareholders to be reminded of what has just happen! I just hope ASW are successful in turning the old business around and that over time the share price might recover back to the 5p level I need to consider exiting gla |
Posted at 23/10/2013 09:46 by callumross Still AVIA on ADVFN. Interesting that it is trading over 2.5p when the cash raised amounts to only about 1.25p per share and this will diminish monthly to meet operating costs. A lot of hope value in the share price at this level! |
Posted at 23/10/2013 08:18 by knigel He clearly does not know enough as funds were raised and the shares were relisted! He has not appeared on this thread before and appears to have his own agenda. Agree no compelling reason to buy in - but look what happen to the DOR share price when it made its first investment... new tech sector investments are the way to go so IF this cash shell makes the right investment(s) it MAY re-rate upwards. One to watch imo and I do not feel an urgent need to sell out yet |
Posted at 24/6/2013 12:48 by christianf12 Further rnsSo they have noticed they need funding. Don't see a problem as long as ASW still supportive. Licence agreement sounds interesting, they were obviously expecting immediate revenue from it. Wonder how long this will drag on for. Avia Health Infrmtcs Statement re. Suspension RNS Number : 7067H Avia Health Informatics PLC 24 June 2013 Avia Health Informatics Plc ("Avia" or "the Company") Suspension from trading of securities on AIM Further to the announcement made by the Company on 1 March 2013, Avia has experienced continued ordering delays in the NHS which has resulted in a deferral of expected revenues. In addition the Company has experienced a delay in entering into an agreement to licence the Company's technology to a third party. This licence agreement was expected to be entered into by the end of June 2013. These factors will lead to a significant working capital shortfall and the directors now believe that without an immediate injection of further capital the Company will be unable to meet its current obligations. The Company has therefore requested the suspension of its shares from trading on AIM, pending clarification of its financial position. The Directors believe that the positive case for its technology remains valid and are seeking the necessary capital to overcome the working capital shortfall. However, should the required capital not be found, it is likely that the Company, or its principal creditors, will seek the appointment of an administrator. Further announcements will be made as and when appropriate. 24 June 2013 Enquiries: Avia Health Informatics Plc +44 (0) 1494 618 503 Jeremy Dale, Chief Executive Tim Morris, Managing Director Allenby Capital (Nominated Adviser and Broker) +44 (0) 20 3328 5656 Nick Naylor Mark Connelly |
Posted at 24/6/2013 12:05 by charmer1_23 Oh Dear, not looking good peeps:AIM Suspension - AVIA Health Informatics plc Date : 24/06/2013 @ 12:00 Source : UK Regulatory (RNS & others) Stock : Avia Health (AVIA) Quote : 7.25 -0.5 (-6.45%) @ 11:32 HOME » LSE » LSE » Avia Health share price AIM Suspension - AVIA Health Informatics plc Alert TIDMAVIA RNS Number : 7017H AIM 24 June 2013 NOTICE 24/06/2013 12:00am TEMPORARY SUSPENSION OF TRADING ON AIM AVIA HEALTH INFORMATICS PLC At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 24/06/2013 12:00am, pending clarification of the Company's financial position. Ordinary shares of 0.5p each, fully paid (B4YSYV6)(GB00B4YSYV If you have any queries relating to the above, please contact the company's nominated adviser on 020 3328 5656. This information is provided by RNS The company news service from the London Stock Exchange END EXCSEEFSLFDSEIM |
Posted at 23/5/2013 21:50 by 29howard This to me has great potential, the orders may be small given the size of the business but there is unlimited growth and with a micro market cap any orderswill benefit the shareprice. Avia Health Informatics PLC User of Odyssey CareAssess wins award Alert TIDMAVIA Avia Health Informatics PLC 14 March 2013 Eric Williams House wins the Early Intervention and Prevention award at the Lang & Buisson Independent Specialist Care Awards for its use of Odyssey CareAssess Avia (AIM: AVIA), the developer and provider of clinical decision support and referral facilitation software, via its wholly owned subsidiary, Plain Healthcare is proud to announce that Eric Williams House, a local government funded care home in Coventry, won the prestigious Early Intervention and Prevention award at the national Lang & Buisson Independent Specialist Care Awards on the 12(th) March, for its use of Odyssey CareAssess. Plain Healthcare, has been working with Eric Williams House and the Godiva Clinical Commissioning Group on the development of Odyssey CareAssess since October 2011. Eric Williams House is a 43 bedded care home for the elderly mentally infirm which historically placed significant demands on the 999 ambulance service and the local emergency department, as well as the out of hours service. Odyssey CareAssess was introduced to support resident centred assessments of health care needs. The Odyssey CareAssess software, specifically designed for care home residents and carers, uses intuitive touchscreen technology, enabling individual problems to be identified, assessed and managed at the earliest stage. Carers and residents are supported in history taking and appropriate outcome generation. The change in process that Odyssey CareAssess enabled has increased staff confidence, knowledge and ensured quality. Many more problems are now identified earlier. When intervention is needed, it is clear to the staff what this might be and it gives a clear timeframe for them to follow. Residents are more frequently effectively managed in-house with the right advice and follow up support, and when outside intervention is required, a robust history can be sent in advance to aid informed decision making by health professionals as to the urgency of next steps. This has enabled early and appropriate intervention regarding, for example, suspected infections - maintaining optimum levels of health for residents. Staff at Eric Williams House quickly embraced the change and the tablet has become a crucial part of the carer toolkit, portable and easy to use with an average of eight uses per day rising to 20 on occasions. Key Outcomes -- 42% reduction in Emergency Department attendance maintained over a 12 month period (verified statistics) -- GP attendance reduced by 75% (unverified) -- Staff, residents and families confident of highest quality care -- Educational structure develops carer knowledge and skills with every use -- Robust records reflecting best practice and current clinical evidence are maintained The Independent Specialist Care Awards draws attention to the best performing private and voluntary sector providers working in the provision of social care services for adults with learning or physical disabilities or mental health conditions whether that be in residential care, homecare or specialist hospitals. Professor Jeremy Dale, Chief Executive of Avia Health Informatics Plc, commented: "We are delighted for Eric Williams House. Their use of Odyssey CareAssess has helped us to develop a robust assessment tool that enables early intervention and appropriate care of the most vulnerable people. To receive an award like this further justifies our commitment to providing high quality clinical decision support that benefits patients, healthcare professionals and service providers alike." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
